RT from the fabulous Ana Correia @alpcorreia
Thrilled to share my Perspective on how #TissueImmunity selectively restrains the growth of metastases - an exciting avenue for developing #Immunotherapies for long-lasting control of #Metastasis
Thanks Lucy Bird and @NatRevImmunol for the opportunity!
šrdcu.be/c4539
#tissueimmunity #immunotherapies #metastasis
#Scientists at St. Jude Childrenās Research Hospital added a #molecular anchor to #chimeric #antigen #receptors (#CARs), increasing the anti-cancer activity of cellular #immunotherapies in #cancer models.
#Biology #Medical #sflorg
https://www.sflorg.com/2023/02/bio02052305.html
#scientists #molecular #chimeric #antigen #receptors #cars #immunotherapies #cancer #biology #medical #sflorg
A research group at the University of Basel has identified a #gene that drives T #lymphocytes (#Tcell) to exhaustion. This finding opens up new approaches for more effective #immunotherapies.
#Biology #Medical #sflorg
https://www.sflorg.com/2023/02/bio02022301.html
#gene #lymphocytes #TCell #immunotherapies #biology #medical #sflorg
RT @NCIsysbio
Dr. Nicholas Graham, @USCSysBio_Lab, et al. @USCViterbi #NCICSBC are investigating #ChimericAntigenReceptor (CAR)-mediated Natural Killer cell signaling to inform the design of #immunotherapies for #multiplemyeloma. https://reporter.nih.gov/search/xb8Mbt37xEO5MhSqAhNPhQ/project-details/10557760
#ncicsbc #chimericantigenreceptor #immunotherapies #multiplemyeloma
RT @BioNTech_Group@twitter.com
We today announced signing an MoU with the UK government to accelerate trials for personalized #mRNA #immunotherapies. Our objective: providing personalized cancer therapies for up to 10k patients by end 2030 in clinical trials or as authorized treatments. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-strategic-partnership-uk-government-provide
š¦š: https://twitter.com/BioNTech_Group/status/1611270532711780352
A new company developing 3-D cell and tissue models of lymph nodes for discovery of #immunotherapies is raising $4.3 million in seed funds. https://sciencebusiness.technewslit.com/?p=44244 #Science #Business #Organoids #ImmuneSystem #LymphNodes #StartUp #AnimalTesting #DrugDiscovery #Finance #VentureCapital #SeedFunds
#immunotherapies #science #business #organoids #immunesystem #lymphnodes #startup #animaltesting #drugdiscovery #finance #venturecapital #seedfunds
I am considering moving my account to a new server that suits my interests a little better. I am working with #tumorimmunology and #immunotherapies so something "sciency" would be great.
Any recommendations from fellow researchers out there?
Please boost!
#science #research #immunology #oncology #immunotherapy #translational
#tumorimmunology #immunotherapies #science #research #immunology #oncology #immunotherapy #translational #changeserver #move #instances
Targeting key #proteins that control the T cell response to stress could help researchers develop more potent #cancer #immunotherapies.
#Tcell #Medical #Biology #sflorg
https://www.sflorg.com/2022/12/med12192202.html
#proteins #cancer #immunotherapies #TCell #medical #biology #sflorg
Targeting key #proteins that control the T cell response to stress could help researchers develop more potent #cancer #immunotherapies.
#Tcell #Medical #Biology #sflorg
https://www.sflorg.com/2022/12/med12192202.html
#proteins #cancer #immunotherapies #TCell #medical #biology #sflorg
This week's special issue on #CellEngineering in #Science (@sciencemagazine) includes:
⢠a review on future of engineered #immunotherapies by Darrell Irvine, Marcela Maus, David Mooney, & Wilson Wong: https://bit.ly/Sci_abq6990
⢠a piece on engineering #bacteria for anti- #cancer therapies by
Candice Gurbati, Nick Arpaia, & Tal Danino: https://bit.ly/Sci_add9667
Be sure to also check out the introduction written by my fantastic colleagues Bryan Ray & Priscilla Kelly: https://bit.ly/Sci_adf8627
#cancer #bacteria #immunotherapies #Science #cellengineering
A developer of #cancer treatments triggered by #tumor #chemistry is partnering with biologic drug maker Regeneron on dual-action cancer #immunotherapies. https://sciencebusiness.technewslit.com/?p=44129 #Science #Business #Biotechnology #Collaboration #Microenvironment #Antibodies
#cancer #tumor #chemistry #immunotherapies #science #business #biotechnology #collaboration #microenvironment #antibodies